$12.73
-0.48-3.63%
Last update: Nov 6, 7:28 PM
ADMA Biologics Inc (ADMA) Stock Price, Quote, News & History
ADMANASDAQ
ADMA Biologics stock surges 23% after beating Q3 2026 earnings, led by a 31% rise in ASCENIV demand and strong margins.
You can purchase shares of ADMA Biologics (NASDAQ:ADMA) through any online brokerage.
Other companies in ADMA Biologics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
ADMA Biologics has a consensus price target of $21.20.
The stock price for ADMA Biologics (NASDAQ: ADMA) is $12.74 last updated November 6, 2026 at 7:28 PM EST.
There are no upcoming dividends for ADMA Biologics.
ADMA Biologics does not have any upcoming earnings scheduled.
There is no upcoming split for ADMA Biologics.
ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk...
